2023 HFSP Nakasone Award
The call for nominations for the 2023 HFSP Nakasone Award is now closed. We expect the next call to open in March 2023.
Nominations are invited for the 2023 HFSP Nakasone Award. Nominations must be submitted using the simple nomination form, which can be downloaded HERE. Instructions are included in the form.
Proposers must provide:
1. The completed nomination form
2. The candidates CV
Nominations are to be submitted by 6 May 2022 by email to Click here to show mail address
The idea for the establishment of the prestigious HFSP Nakasone Award was proposed in Tokyo in July 2009 during the HFSP 20th anniversary celebrations in the presence of former Prime Minister Nakasone of Japan. The award honours the vision of former Prime Minister Nakasone for his efforts to launch a program of support for international collaboration and to foster early career scientists in a global context. Mr. Nakasone presented the idea of the Human Frontier Science Program (HFSP) at the G7 economic summit in Venice in 1987 and, after an intense phase of preparation, the International Human Frontier Science Program Organization was established in Strasbourg, France in the autumn of 1989 to implement the Program. Since then it has supported approximately 7500 scientists from over 70 countries, 28 of whom have gone on to win the Nobel Prize.
The HFSP Nakasone Award is designed to honour scientists who have undertaken frontier-moving research in biology, encompassing conceptual, experimental or technological breakthroughs. Both senior and junior scientists are eligible and peer-recognised excellence is the major criterion for selection. However, the jury will pay particular attention to recent breakthroughs by early career scientists. The prize is open to all scientists, not only those who have received funding within the HFSP.
The awardee(s) will receive an unrestricted research grant of USD 15,000, a gold medal and a personalised certificate. The award ceremony will be held at the annual HFSP Awardees Meeting, where the awardee will deliver the HFSP Nakasone Lecture.
Proposers should take into account the following points when choosing nominees:
The award is for scientific excellence of a clearly defined discovery or series of discoveries in basic life science research, in accord with HFSP’s mission to support basic research into the “complex mechanisms of living organisms”. Areas have traditionally ranged from molecular and cellular approaches to biological functions to systems neuroscience including cognitive functions. However, all levels of complexity involving mechanisms of biological phenomena or the interactions between organisms themselves and with the environment will be considered.
The discovery or discoveries shall:
- be frontier contributions to knowledge in the life sciences;
- have resulted in a notable conceptual breakthrough that has had significant consequences for scientists throughout the world;
- be identifiable via (a) specific publication(s).
Experimental, conceptual and technological contributions are all eligible.
The award is not for life-time achievement.
This is an open award, not restricted to HFSP funded scientists and there are no restrictions on who may be nominated. However, HFSP has a focus on early career scientists through its Fellowship and Research Grant funding programs and so nominations of scientists who have achieved a recent significant breakthrough at an early stage of their careers are especially encouraged.
Both the nomination and the nominees may be from any country.
Up to two scientists may be jointly nominated and share the HFSP Nakasone Award. These scientists should be co-authors on breakthrough publications or collaborators of key discoveries. Separate nominees for the same breakthrough will not be considered.
Self-nominations are not accepted.
Coordinated multiple nominations for a candidate(s) will be considered as a single nomination. While nominations for a scientist may be submitted by several different parties, there is no advantage to submitting several nominations for the same person. Multiple nominations will be merged for the purpose of the review.
Members of the HFSPO Board of Trustees and Council of Scientists are not eligible for nomination and may not nominate candidates to avoid a perception of conflict of interest. The current members may be consulted here: Board of Trustees; Council of Scientists.
2022 Aviv Regev of Genentech, a member of the Roche Group, San Francisco, USA for unravelling the biological processes controlling cellular phenotype through innovative computational, mathematical, and experimental approaches applied to single-cell genomics.
2022 Franz-Ulrich Hartl of the Max Planck Institute of Biochemistry, Martinsried, Germany and Arthur L. Horwich of Yale University, New Haven, USA for their discoveries revealing the functions and mechanisms of chaperone-mediated protein folding and the implication of their work in understanding human disease.
2021 Anthony Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany and Clifford Brangwynne of Princeton University and the Howard Hughes Medical Institute, USA for their discovery of a new state of biological matter, phase-separated macromolecule condensates, that play an important role in cell organisation, gene regulation, signalling and pathology.
2020 Angelika Amon of the Koch Institute for Integrative Cancer Research at MIT, Cambridge, USA for discovering aneuploidy-induced cellular changes and their contribution to tumorigenesis.
2019 Michael Hall of the Biozentrum at the University of Basel, Switzerland for the discovery of the master regulator of cell growth, the target of rapamycin (TOR) kinase.
2018 Svante Pääbo from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany for his discovery of the extent to which hybridization with Neanderthals and Denisovans has shaped the evolution of modern humans, and his development of techniques for sequencing DNA from fossils.
2017 David Julius from the University of California San Francisco, USA for his discovery of the molecular mechanism of thermal sensing in animals.
2016 Emmanuelle Charpentier from the Max Planck Institute for Infection Biology in Berlin, Germany and Jennifer Doudna from the University of California at Berkeley, USA for their groundbreaking work on the CRISPR-Cas 9 system.
2015 James Collins from Boston University, USA for his innovative work on synthetic gene networks and programmable cells.
2014 Uri Alon from the Weizmann Institute of Science, Israel for his groundbreaking work on network motifs.
2013 Stephen Quake from Stanford University, USA for his pioneering work advancing biological measurement techniques.
2012 Gina Turrigiano from Brandeis University, Waltham, USA for introducing the concept of homeostatic synaptic plasticity.
2011 Michael Elowitz from the California Institute of Technology, USA for his key studies on gene expression noise.
2010 Karl Deisseroth from Stanford University, USA for his pioneering work on the application of microbial opsins as "optogenetic" tools in neurobiology.